Serum immune complex containing thrombospondin-1: a novel biomarker for early rheumatoid arthritis

被引:23
|
作者
Ohyama, Kaname [1 ,2 ]
Kawakami, Atsushi [3 ]
Tamai, Mami [3 ]
Baba, Miyako [1 ]
Kishikawa, Naoya [1 ]
Kuroda, Naotaka [1 ]
机构
[1] Nagasaki Univ, Dept Environm & Pharmaceut Sci, Grad Sch Biomed Sci, Nagasaki 8528521, Japan
[2] Nagasaki Univ, Res Ctr Genom Instabil & Carcinogenesis NRGIC, Nagasaki 8528521, Japan
[3] Nagasaki Univ, Dept Immunol & Rheumatol, Grad Sch Biomed Sci, Unit Translat Med, Nagasaki 8528521, Japan
关键词
CLASSIFICATION CRITERIA; RHEUMATOLOGY/EUROPEAN LEAGUE; AMERICAN-COLLEGE; ANGIOGENESIS;
D O I
10.1136/annrheumdis-2012-201305
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1916 / 1917
页数:2
相关论文
共 50 条
  • [21] A novel thrombospondin-1 variant as a potential diagnostic biomarker and therapeutic target in canine mammary tumor and osteosarcoma cells
    Hong, Yukyung
    Baik, Heyeon
    Lee, Jeongmin
    Oh, Won Seok
    Ryu, Junsun
    Baek, Seung Joon
    JOURNAL OF VETERINARY SCIENCE, 2025, 26 (02)
  • [22] THROMBOSPONDIN-1: A NOVEL CHONDROITIN SULFATE TARGET FOR OSTEOARTHRITIS TREATMENT
    Verges, J.
    Calamia, V
    Lourido, L.
    Mateos, J.
    Fernandez-Puente, P.
    Rocha, B.
    Fernandez-Costa, C.
    Montell, E.
    Ruiz-Romero, C.
    Blanco, F. J.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2013, 113 : 38 - 38
  • [23] THROMBOSPONDIN-1: A NOVEL CHONDROITIN SULFATE TARGET FOR OSTEOARTHRITIS TREATMENT
    Calamia, V
    Lourido, L.
    Mateos, J.
    Fernandez-Puente, P.
    Rocha, B.
    Fernandez-Costa, C.
    Montell, E.
    Verges, J.
    Ruiz-Romero, C.
    Blanco, F. J.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2013, 113 : 21 - 21
  • [24] Immune Complexome Analysis of Serum and Its Application in Screening for Immune Complex Antigens in Rheumatoid Arthritis
    Ohyama, Kaname
    Ueki, Yukitaka
    Kawakami, Atsushi
    Kishikawa, Naoya
    Tamai, Mami
    Osaki, Makoto
    Kamihira, Shimeru
    Nakashima, Kenichiro
    Kuroda, Naotaka
    CLINICAL CHEMISTRY, 2011, 57 (06) : 905 - 909
  • [25] THROMBOSPONDIN-1: A NOVEL CHONDROITIN SULFATE TARGET FOR OSTEOARTHRITIS TREATMENT
    Calamia, V.
    Lourido, L.
    Mateos, J.
    Fernandez-Puente, P.
    Rocha, B.
    Fernandez-Costa, C.
    Montell, E.
    Verges, J.
    Ruiz-Romero, C.
    Blanco, F. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 808 - 808
  • [26] Maternal serum thrombospondin-1 is significantly altered in cases with established preeclampsia
    Ulu, Ipek
    Cekmez, Yasemin
    Kopuk, Sule Yildirim
    Ozer, Nida
    Yogurtcuoglu, Eser Evrim
    Angin, Pinar
    Kiran, Guerkan
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2019, 32 (15): : 2543 - 2546
  • [27] Serum thrombospondin-1 is altered in patients with hemorrhagic fever with renal syndrome
    Liu, Zhengwen
    Zhao, Qianzi
    Han, Qunying
    Gao, Maicang
    Zhang, Ni
    JOURNAL OF MEDICAL VIROLOGY, 2008, 80 (10) : 1799 - 1803
  • [28] High serum levels of thrombospondin-1 in patients with idiopathic interstitial pneumonia
    Ide, Mioko
    Ishii, Hiroshi
    Mukae, Hiroshi
    Iwata, Atsuko
    Sakamoto, Noriho
    Kadota, Jun-ichi
    Kohno, Shigeru
    RESPIRATORY MEDICINE, 2008, 102 (11) : 1625 - 1630
  • [29] Serum cotinine as a biomarker of tobacco exposure and the association with treatment response in early rheumatoid arthritis
    Maska, Leann B.
    Sayles, Harlan R.
    O'Dell, James R.
    Curtis, Jeffrey R.
    Bridges, S. Louis, Jr.
    Moreland, Larry W.
    Cofield, Stacey S.
    Mikuls, Ted R.
    ARTHRITIS CARE & RESEARCH, 2012, 64 (12) : 1804 - 1810
  • [30] The utility of serum Thrombospondin-1 levels as a prognostic marker in ischemic stroke
    Al Qawasmeh, M.
    Alhusban, A.
    Alfwaress, F.
    Alhusban, L.
    Obiedat, D.
    El-Salem, K.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405